Reta 10mg

📩 To order — email us directly:

Email: helixcorelab@gmail.com

This product is fulfilled manually. Email us to confirm availability and complete your order.

Reta is a next-generation triple-receptor agonist currently under active clinical investigation for its activity at GLP-1, GIP, and glucagon receptor pathways simultaneously. This tri-agonist mechanism has produced significant results in metabolic research, making it one of the most discussed research compounds in the peptide community.

Unlike single-receptor GLP-1 compounds, the triple-receptor approach provides a broader metabolic signal. It has been the subject of multiple Phase 2 and Phase 3 clinical trials and is supplied here for laboratory research purposes only.

Product Details:

• Purity: ≥99% — third-party HPLC verified
• Form: Lyophilized powder
• Amount: 10mg per vial
• Storage: -20°C in a dry, controlled environment
• Intended Use: Laboratory research and analytical applications only

How to Order:
Because this compound requires manual fulfillment, we do not process orders through the standard checkout. Email helixcorelab@gmail.com with your order. We typically respond within a few hours.

Important Disclaimer:
This product is not approved by Health Canada or any regulatory authority for human or veterinary use. It is not intended for consumption, injection, or therapeutic application. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.